BDBM419271 (3S)-1-[5-[Difluoro(phenyl)methyl]-3-[[2-ethynyl-6-[3-(trifluoromethyl)diazirin-3-yl]phenyl]methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol::US10457684, Example 15

SMILES C#Cc1cccc(C2(C(F)(F)F)N=N2)c1Cn1nnc2c(N3CC[C@H](O)C3)nc(C(F)(F)c3ccccc3)nc21

InChI Key InChIKey=BMTBYTRAWIGTPC-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419271   

TargetCannabinoid receptor 2(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 419271BDBM419271((3S)-1-[5-[Difluoro(phenyl)methyl]-3-[[2-ethynyl-6...)
Affinity DataKi:  58nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2020
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 419271BDBM419271((3S)-1-[5-[Difluoro(phenyl)methyl]-3-[[2-ethynyl-6...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2020
Entry Details
US Patent